MA42048A - Dérivés d'aminoesters - Google Patents

Dérivés d'aminoesters

Info

Publication number
MA42048A
MA42048A MA042048A MA42048A MA42048A MA 42048 A MA42048 A MA 42048A MA 042048 A MA042048 A MA 042048A MA 42048 A MA42048 A MA 42048A MA 42048 A MA42048 A MA 42048A
Authority
MA
Morocco
Prior art keywords
aminoesters
derivatives
aminoesters derivatives
Prior art date
Application number
MA042048A
Other languages
English (en)
Inventor
Gabriele Amari
Elisabetta Armani
Charles Baker-Glenn
Wesley Blackaby
Naimisha Trivedi
De Pöel Hervé Van
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA42048A publication Critical patent/MA42048A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
MA042048A 2015-05-07 2016-05-05 Dérivés d'aminoesters MA42048A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15166703 2015-05-07

Publications (1)

Publication Number Publication Date
MA42048A true MA42048A (fr) 2018-03-14

Family

ID=53177142

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042048A MA42048A (fr) 2015-05-07 2016-05-05 Dérivés d'aminoesters

Country Status (5)

Country Link
US (2) US9809582B2 (fr)
EP (1) EP3292118A1 (fr)
AR (1) AR104532A1 (fr)
MA (1) MA42048A (fr)
WO (1) WO2016177849A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111161344B (zh) * 2019-12-31 2021-08-10 广州永士达医疗科技有限责任公司 基于oct设备的气道弹性测量方法、***、设备及介质
FI20225388A1 (en) 2022-05-05 2023-11-06 Equinorm Ltd New heterocyclic compounds, preparation methods and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012168226A1 (fr) * 2011-06-06 2012-12-13 Chiesi Farmaceutici S.P.A. Dérivés d'alcools 1-phényl-2-pyridinyl alkyliques utilisés en tant qu'inhibiteurs de phosphodiestérase
CA2893622A1 (fr) 2012-12-05 2014-06-12 Chiesi Farmaceutici S.P.A. Derives de phenylethylpyridine en tant qu'inhibiteurs de pde4
EP2928879B1 (fr) * 2012-12-05 2018-02-28 Chiesi Farmaceutici S.p.A. Dérivés de phenylethylpyridine comme inhibiteurs de pde4 et en tant qu'antagonistes des récepteurs muscariniques
TW201439089A (zh) 2012-12-05 2014-10-16 Chiesi Farma Spa 新穎化合物
TW201607944A (zh) 2013-12-05 2016-03-01 吉斯藥品公司 雜芳基衍生物
CA2932486A1 (fr) 2013-12-05 2015-06-11 Chiesi Farmaceutici S.P.A. Derives benzhydryle pour le traitement de maladies respiratoires
US9763924B2 (en) 2014-06-05 2017-09-19 Chiesi Farmaceutici S.P.A. Aminoester derivatives
US9326976B2 (en) 2014-06-05 2016-05-03 Chiesi Farmaceutici S.P.A. Carbamate derivatives

Also Published As

Publication number Publication date
US20180016265A1 (en) 2018-01-18
WO2016177849A1 (fr) 2016-11-10
US9809582B2 (en) 2017-11-07
AR104532A1 (es) 2017-07-26
EP3292118A1 (fr) 2018-03-14
US20160326147A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
DK3529248T3 (da) Farmaceutiske sammensætninger
DK3297649T3 (da) Peptid-oligonukleotid-konjugater
DK3268047T3 (da) Amatoxin/antistof-konjugater
DK3319956T3 (da) Substituerede oxopyridinderivater
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
MA40770A (fr) Dérivés d'imidazoles pentacyclic fusionnés
MA50541A (fr) Formulations pharmaceutiques
MA50657A (fr) Formulations de niraparib
DK3529240T3 (da) Farmaceutiske forbindelser
BR112017027227A2 (pt) Agente anti-câncer
MA42303A (fr) Formulations pharmaceutiques
DK3244878T3 (da) Faste orale sammensætningsformer
FR3033706B3 (fr) Simulateur d'escalier
ES2841649T5 (es) Composición farmacéutica
MA44987A (fr) Formulations de médicaments améliorées
DK3390412T3 (da) Vandopløselige derivater af 3,5-diphenyl-diazolforbindelser
DK3280447T3 (da) Farmaceutiske formuleringer
MA50068A (fr) Formulations de copanlisib
DK3645513T3 (da) Benzazepinderivater
MA49708A (fr) Dérivés de dihétérocycle liés à cycloalkyle
DK3528791T3 (da) Dispergible sammensætninger
ES2965944T3 (es) Composición microbicida
DK3512518T3 (da) Buprenophinformuleringer med langvarig frigivelse
MA42048A (fr) Dérivés d'aminoesters
KR20180084728A (ko) 구강용 조성물